Reference
Alhaffaf F, et al. NLRC4 mutation as a cause of very early onset-inflammatory bowel disease (VEO-IBD) refractory to treatment. Journal of Pediatric Gastroenterology and Nutrition 72: 623, May 2021. Available from: URL: http://doi.org/10.1097/MPG.0000000000003177 [abstract]
Rights and permissions
About this article
Cite this article
Anakinra/tocilizumab. Reactions Weekly 1860, 40 (2021). https://doi.org/10.1007/s40278-021-97495-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97495-0